Great Lakes Research Institute

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Fatty liver disease (MASLD/MASH)

Running trials

• Active, not recruiting

  A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  NCT05519475· Phase 2· Regeneron Pharmaceuticals· Source